TESARO
TESARO is a biopharmaceutical company that identifies, acquires, develops and commercializes cancer therapeutics.
Business Model:
Revenue: $213M
Employees: 501-1,000
Rankings
Industries / Tags:
Detailed TESARO Information
TESARO was acquired by
GlaxoSmithKline.
The acquisition happend on 2018-12-03.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 1000 Winter Street
City: Waltham
State: MA
Zip: 02451
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$155M
Raised Total:$407M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
TESARO is a biopharmaceutical company that identifies, acquires, develops and commercializes cancer therapeutics.
Contact Phone:
+13399700900
Contact Email:
TESARO went public on 6/28/2012 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/28/2012
IPO Valuation:
$360M
Ticker Symbol:
TSRO
IPO Price:
$13.5/share
Amount Raised:
$81M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
